Literature DB >> 31288913

In Reply.

Sebastian Rauer.   

Abstract

Year:  2019        PMID： 31288913      PMCID： PMC6630166          DOI： 10.3238/arztebl.2019.0345

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Lyme Neuroborreliosis.

Authors:  Sebastian Rauer; Stefan Kastenbauer; Volker Fingerle; Klaus-Peter Hunfeld; Hans-Iko Huppertz; Rick Dersch
Journal:  Dtsch Arztebl Int       Date:  2018-11-09       Impact factor: 5.594

2.  Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

Authors:  M S Klempner; L T Hu; J Evans; C H Schmid; G M Johnson; R P Trevino; D Norton; L Levy; D Wall; J McCall; M Kosinski; A Weinstein
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

3.  A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.

Authors:  B A Fallon; J G Keilp; K M Corbera; E Petkova; C B Britton; E Dwyer; I Slavov; J Cheng; J Dobkin; D R Nelson; H A Sackeim
Journal:  Neurology       Date:  2007-10-10       Impact factor: 9.910

4.  Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.

Authors:  L B Krupp; L G Hyman; R Grimson; P K Coyle; P Melville; S Ahnn; R Dattwyler; B Chandler
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.